Free Trial

iRadimed (IRMD) Stock Price, News & Analysis

iRadimed logo
$61.83 +0.29 (+0.47%)
As of 01:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iRadimed Stock (NASDAQ:IRMD)

Key Stats

Today's Range
$61.20
$62.25
50-Day Range
$51.01
$61.54
52-Week Range
$42.34
$63.29
Volume
69,139 shs
Average Volume
43,911 shs
Market Capitalization
$786.48 million
P/E Ratio
39.89
Dividend Yield
1.10%
Price Target
$72.00
Consensus Rating
Buy

Company Overview

iRadimed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

IRMD MarketRank™: 

iRadimed scored higher than 94% of companies evaluated by MarketBeat, and ranked 75th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iRadimed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    iRadimed has received no research coverage in the past 90 days.

  • Read more about iRadimed's stock forecast and price target.
  • Earnings Growth

    Earnings for iRadimed are expected to grow by 20.48% in the coming year, from $1.66 to $2.00 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iRadimed is 39.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.54.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iRadimed is 39.89, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.43.

  • Price to Book Value per Share Ratio

    iRadimed has a P/B Ratio of 9.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about iRadimed's valuation and earnings.
  • Percentage of Shares Shorted

    2.97% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in iRadimed has recently increased by 3.75%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    iRadimed pays a meaningful dividend of 1.12%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    iRadimed has only been increasing its dividend for 1 years.

  • Dividend Coverage

    The dividend payout ratio of iRadimed is 43.87%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, iRadimed will have a dividend payout ratio of 34.00% next year. This indicates that iRadimed will be able to sustain or increase its dividend.

  • Read more about iRadimed's dividend.
  • Percentage of Shares Shorted

    2.97% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in iRadimed has recently increased by 3.75%, indicating that investor sentiment is decreasing.
  • News Sentiment

    iRadimed has a news sentiment score of 1.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for iRadimed this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, iRadimed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.80% of the stock of iRadimed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    92.34% of the stock of iRadimed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about iRadimed's insider trading history.
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Iradimed Corp Bottom Line Rises In Q1
Iradimed Announces Quarterly Results
See More Headlines

IRMD Stock Analysis - Frequently Asked Questions

iRadimed's stock was trading at $55.00 on January 1st, 2025. Since then, IRMD shares have increased by 12.4% and is now trading at $61.83.

iRadimed Corporation (NASDAQ:IRMD) released its quarterly earnings data on Thursday, February, 13th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by $0.05. The medical equipment provider had revenue of $19.39 million for the quarter, compared to the consensus estimate of $19.09 million. iRadimed had a trailing twelve-month return on equity of 23.28% and a net margin of 26.33%.
Read the conference call transcript
.

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iRadimed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Broadcom (AVGO) and Alphabet (GOOG).

Company Calendar

Last Earnings
2/13/2025
Record date for 5/30 Dividend
5/20/2025
Ex-Dividend for 5/30 Dividend
5/20/2025
Dividend Payable
5/30/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:IRMD
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$72.00
High Stock Price Target
$72.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+17.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
39.70
Forward P/E Ratio
37.07
P/E Growth
N/A
Net Income
$19.23 million
Pretax Margin
33.23%

Debt

Sales & Book Value

Annual Sales
$73.24 million
Cash Flow
$1.61 per share
Price / Cash Flow
38.24
Book Value
$6.85 per share
Price / Book
8.98

Miscellaneous

Free Float
8,036,000
Market Cap
$782.79 million
Optionable
Optionable
Beta
0.91

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:IRMD) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners